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Effects of Medications on Cognitive Function and Falls in Older African 
Americans with Diabetes 
Diana Alnemri, Robin Casten* 
 
 
Introduction: Potentially-inappropriate medications (PIMs) are medications that have 
increased rates of adverse drug events in older adults. Medications with anticholinergic 
activity are classified as PIMs since they can lead to cognitive dysfunction and 
increased fall risk. PIM use is higher among African Americans (AA) than Whites.  
Methods: This study explored relationships among cognitive function, falls, and PIMs in 
AAs with diabetes. This study recruited AAs with diabetes (n=99, age ≥60yrs) who were 
seen in the Emergency Department (ED), and were enrolled in a trial of a behavioral 
intervention to improve diabetes management. PIMs were based on the Beer’s criteria 
and the Anticholinergic Cognitive Burden scale (ACB) score. The Montreal Cognitive 
Assessment (MOCA) was used to characterize cognitive impairment. Falls were 
recorded via EMR and a questionnaire.  
Results: MOCA scores were not significantly correlated with PIMs use or ACB scores 
(PIMs: r=-.101, p=0.318; ACB: r=-.110, p=0.283). MOCA scores were, however, 
negatively correlated with the duration of diabetes, and this was upheld in a regression 
in which age was controlled (r=-0.274, p=0.005). Of 47 subjects who were questioned 
about falls, 20 subjects had at least one fall in the past 12 months, females having more 
falls than males (F=19, M=1). Although the relationship between falls and PIMs and falls 
and ACB score (p=0.925; p=0.122) was insignificant, greater worry about falling was 
related to higher ACB scores (p=0.013). 
Discussion: In sum, results suggests that diabetes duration is related to cognitive 
function, even when age is controlled. Females were more likely to have fallen, perhaps 
due to increased age or diabetes duration.   
 
 
